Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report

RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response

(2012) Jiping Wang et al.   Cardiovascular Diabetology

Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells

(2012) Hong Li et al.   Cardiovascular Diabetology

Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure

(2011) Jasper W.L. Hartog et al.   EUROPEAN JOURNAL OF HEART FAILURE

Blockade of Renin-Angiotensin System Attenuates Advanced Glycation End Products-Mediated Signaling Pathways

(2011) Masashi Kamioka et al.   Journal of Atherosclerosis and Thrombosis

Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells

(2010) Ke Yang et al.   Cardiovascular Diabetology

Oxidative Stress and Diabetic Complications

(2010) Ferdinando Giacco et al.   CIRCULATION RESEARCH

The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study

(2010) Kunihiro Matsushita et al.   DIABETES

Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities

(2010) Jason J. Gajarsa et al.   HEART FAILURE REVIEWS

Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase

(2010) Aino Soro-Paavonen et al.   JOURNAL OF HYPERTENSION

Predictors of Heart Failure in Patients With Stable Coronary Artery Disease

(2009) Eldrin F. Lewis et al.   Circulation-Heart Failure

HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study

(2008) A. Pazin-Filho et al.   DIABETOLOGIA

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡

(2008) Kenneth Dickstein et al.   EUROPEAN JOURNAL OF HEART FAILURE

Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression

(2007) Sho-ichi Yamagishi et al.   MICROVASCULAR RESEARCH